Navigation Links
Kallo Announces Purchase Order For Its Specialist EMR - EMCURx
Date:8/21/2012

MARKHAM, Ontario, Aug. 21, 2012 /PRNewswire/ -- Following a marketing strategy change, Kallo Inc. today announced the acceptance of a purchase order for EMCURx, the only Electronic Medical Record System (EMR) designed for Clinical Specialists in Canada.

"The response to EMCURx has been very encouraging and we look forward to serving Clinical Specialists in Canada and other parts of the world." said Vince Leitao, President and COO. "While the EMR marketplace is crowded with products that do not meet expectations of Clinical Specialists, Kallo's EMCURx is the only Electronic Medical Records System that is designed for Specialists. It is intuitive, easy to use and fulfills Canadian and US regulatory compliances. Easy and seamless interface, with other internal and external applications in the Specialists' practice including Laboratory Information Systems (LIS), Pharmacy Information Systems (PIS), and Provincial HIALs, provides connectivity as it should be."

ABOUT
Kallo, Inc., a medical information company, engaging in the manufacture and development of software that assists physicians and healthcare providers to streamline patient information and workflow. Kallo software solutions include Electronic Medical Record (EMR), Picture Archiving & Communication System (PACS) and Medical Device Connectivity (MDC) that gathers medical information from various sources and deposits into the EMR of each patient. Kallo Inc. also provides Mobile Clinics, Clinical and Administrative Command Centers packaged with Best in Class Medical Devices and Medical Software solutions to ensure a holistic healthcare solution.

"We are excited at the generation of revenue from EMCURx" Concluded Vince Leitao.

Kallo Inc., is a publicly traded company, listed on the OTC markets, (otcmarkets.com) stock symbol KALO.OB

Media contact:
John Cecil or Vince Leitao
416-246-9997
http://www.kalloinc.ca


'/>"/>
SOURCE Kallo Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Market response to Kallo technology
2. CryoLife Announces Initiation of Quarterly Cash Dividend
3. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
4. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
5. Angeion Announces Name Change and New Trading Symbol Effective Tuesday, August 21, 2012
6. VWR Funding, Inc. Announces Proposed Offering Of Senior Notes
7. VWR Funding, Inc. Announces Tender Offer Of Existing PIK Toggle Notes
8. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
9. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
10. ShangPharma Announces Second Quarter 2012 Results
11. Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... Dec. 8, 2016  Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
Breaking Medicine News(10 mins):